<SEC-DOCUMENT>0000921895-22-002078-index.html : 20220623 <SEC-HEADER>0000921895-22-002078.hdr.sgml : 20220623 <ACCEPTANCE-DATETIME>20220623161229 ACCESSION NUMBER: 0000921895-22-002078 CONFORMED SUBMISSION TYPE: DFAN14A PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20220623 DATE AS OF CHANGE: 20220623 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: PharmaCyte Biotech, Inc. CENTRAL INDEX KEY: 0001157075 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 621772151 STATE OF INCORPORATION: NV FISCAL YEAR END: 0430 FILING VALUES: FORM TYPE: DFAN14A SEC ACT: 1934 Act SEC FILE NUMBER: 001-40699 FILM NUMBER: 221035633 BUSINESS ADDRESS: STREET 1: 23046 AVENIDA DE LA CARLOTA, SUITE 600 CITY: LAGUNA HILLS STATE: CA ZIP: 92653 BUSINESS PHONE: (917) 595.2850 MAIL ADDRESS: STREET 1: 23046 AVENIDA DE LA CARLOTA, SUITE 600 CITY: LAGUNA HILLS STATE: CA ZIP: 92653 FORMER COMPANY: FORMER CONFORMED NAME: NUVILEX, INC. DATE OF NAME CHANGE: 20090324 FORMER COMPANY: FORMER CONFORMED NAME: EFOODSAFETY COM INC DATE OF NAME CHANGE: 20010808 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Iroquois Capital Management, LLC CENTRAL INDEX KEY: 0001481867 IRS NUMBER: 010786483 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: DFAN14A BUSINESS ADDRESS: STREET 1: 641 LEXINGTON AVENUE STREET 2: 26TH FLOOR CITY: NEW YORK, STATE: NY ZIP: 10022 BUSINESS PHONE: 212.974.3070 MAIL ADDRESS: STREET 1: 641 LEXINGTON AVENUE STREET 2: 26TH FLOOR CITY: NEW YORK, STATE: NY ZIP: 10022 </SEC-HEADER> <DOCUMENT> <TYPE>DFAN14A <SEQUENCE>1 <FILENAME>dfan14a11375004_06232022.htm <TEXT> Document 1 - file: dfan14a11375004_06232022.htm
</DOCUMENT> <DOCUMENT> <TYPE>DFAN14A <SEQUENCE>2 <FILENAME>ex1todfan14a11375004_062322.pdf <DESCRIPTION>EXHIBIT 1 - AMENDMENT NO. 1 TO THE SCHEDULE 13D <TEXT> Document 2 - file: ex1todfan14a11375004_062322.pdf
</DOCUMENT> </SEC-DOCUMENT>